Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Other financing activities (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Other financing activities for 2 consecutive years, with $134000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Other financing activities fell 86.6% to $134000.0 in Q2 2025 year-over-year; TTM through Sep 2025 was $239000.0, a 85.01% decrease, with the full-year FY2024 number at $853000.0, up 2484.85% from a year prior.
  • Other financing activities was $134000.0 for Q2 2025 at Mereo BioPharma, up from $65000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.0 million in Q2 2024 to a low of $40000.0 in Q4 2024.